Detalles de la búsqueda
1.
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.
J Virol
; 87(3): 1708-19, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23175374
2.
Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.
J Gen Virol
; 92(Pt 1): 128-40, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21169215
3.
HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat.
Biochem Biophys Res Commun
; 370(1): 22-6, 2008 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-18329382
4.
Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation.
Biochem Biophys Res Commun
; 366(1): 29-35, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18036339
5.
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates.
PLoS One
; 13(11): e0207794, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30500852
6.
Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
AIDS Res Hum Retroviruses
; 23(1): 33-42, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17263630
7.
Nedd4-mediated increase in HIV-1 Gag and Env proteins and immunity following DNA-vaccination of BALB/c mice.
PLoS One
; 9(3): e91267, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24614057
8.
Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.
Virology
; 447(1-2): 274-84, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24210124
9.
Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses.
J Virol Methods
; 163(2): 287-94, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19878696
10.
HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
Virology
; 366(1): 197-211, 2007 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17499328
11.
Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits.
Vaccine
; 24(8): 1225-34, 2006 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16219399
12.
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
Virology
; 348(2): 341-53, 2006 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16460776
13.
Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
Virology
; 346(1): 151-68, 2006 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16325880
14.
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.
J Virol
; 80(8): 3732-42, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16571790
15.
Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate.
J Med Primatol
; 34(5-6): 226-36, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16128917
Resultados
1 -
15
de 15
1
Próxima >
>>